ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 13 analysts with an average price target of $11.25. This is a potential upside of $9.81 (681.25%) from yesterday's end of day stock price of $1.44.

Allogene Therapeutics's activity chart (see below) currently has 111 price targets and 122 ratings on display. The stock rating distribution of ALLO is 83.72% BUY and 16.28% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.99% with an average time for these price targets to be met of 78.4 days.

Highest price target for ALLO is $14, Lowest price target is $4.6, average price target is $7.3.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 19-Mar-2025. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 36 are a BUY (83.72%), 7 are a HOLD (16.28%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$6.45 (416.13%)

$9

13 days ago
(19-Mar-2025)

0/10 (0%)

$6.31 (373.37%)

Buy

$14

$12.45 (803.23%)

18 days ago
(14-Mar-2025)

1/3 (33.33%)

$12.06 (621.65%)

192

Hold

$5

$3.45 (222.58%)

18 days ago
(14-Mar-2025)

1/9 (11.11%)

$3.06 (157.73%)

148

Buy

$9

$7.45 (480.65%)

$11

4 months 18 days ago
(14-Nov-2024)

2/8 (25%)

$6.54 (265.85%)

3

Buy

$10

$8.45 (545.16%)

$11

4 months 24 days ago
(08-Nov-2024)

0/2 (0%)

$6.92 (224.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 22.99

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 1 price targets and 6 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $30.49

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Asthika Goonewardene with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?